Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
Yuqian Liao,1,* Yulu Liao,2,* Jun Li,2 Junyu Li,2 Ying Fan,3 Binghe Xu3 1Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 2Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People&rsquo...
Main Authors: | Liao Y, Li J, Fan Y, Xu B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/polymorphisms-in-aurka-and-aurkb-are-associated-with-the-survival-of-t-peer-reviewed-article-CMAR |
Similar Items
-
Avaliação dos genes AURKA e AURKB em pacientes pediátricos portadores de leucemia linfóide aguda
by: Dutra, Luana Leticia Alves
Published: (2015) -
The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
by: Seyyed Asadolah Mousavi, et al.
Published: (2013-03-01) -
The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
by: Seyyed AsadoLah Mousavi, et al.
Published: (2013-01-01) -
Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
by: Yan Yang, et al.
Published: (2020-01-01) -
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
by: Ruijuan Du, et al.
Published: (2021-01-01)